Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3277298539;98540;98541 chr2:178539751;178539750;178539749chr2:179404478;179404477;179404476
N2AB3113193616;93617;93618 chr2:178539751;178539750;178539749chr2:179404478;179404477;179404476
N2A3020490835;90836;90837 chr2:178539751;178539750;178539749chr2:179404478;179404477;179404476
N2B2370771344;71345;71346 chr2:178539751;178539750;178539749chr2:179404478;179404477;179404476
Novex-12383271719;71720;71721 chr2:178539751;178539750;178539749chr2:179404478;179404477;179404476
Novex-22389971920;71921;71922 chr2:178539751;178539750;178539749chr2:179404478;179404477;179404476
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACT
  • RefSeq wild type template codon: TGA
  • Domain: Ig-155
  • Domain position: 65
  • Structural Position: 153
  • Q(SASA): 0.4265
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/I rs1163729764 0.099 0.002 N 0.32 0.124 0.331876078066 gnomAD-2.1.1 1.21E-05 None None None None N None 0 5.8E-05 None 0 5.57E-05 None 0 None 0 0 0
T/I rs1163729764 0.099 0.002 N 0.32 0.124 0.331876078066 gnomAD-4.0.0 4.77359E-06 None None None None N None 0 4.57331E-05 None 0 2.77331E-05 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.11 likely_benign 0.1303 benign -1.144 Destabilizing 0.055 N 0.537 neutral N 0.516953941 None None N
T/C 0.3756 ambiguous 0.4462 ambiguous -0.759 Destabilizing 0.968 D 0.652 neutral None None None None N
T/D 0.5185 ambiguous 0.6032 pathogenic -0.668 Destabilizing 0.157 N 0.585 neutral None None None None N
T/E 0.4381 ambiguous 0.5323 ambiguous -0.575 Destabilizing 0.272 N 0.582 neutral None None None None N
T/F 0.2786 likely_benign 0.3519 ambiguous -0.962 Destabilizing 0.567 D 0.695 prob.neutral None None None None N
T/G 0.3948 ambiguous 0.4546 ambiguous -1.488 Destabilizing 0.157 N 0.579 neutral None None None None N
T/H 0.3057 likely_benign 0.3834 ambiguous -1.627 Destabilizing 0.832 D 0.695 prob.neutral None None None None N
T/I 0.1248 likely_benign 0.1499 benign -0.284 Destabilizing 0.002 N 0.32 neutral N 0.499618974 None None N
T/K 0.2588 likely_benign 0.3318 benign -0.735 Destabilizing 0.157 N 0.584 neutral None None None None N
T/L 0.1051 likely_benign 0.127 benign -0.284 Destabilizing 0.06 N 0.565 neutral None None None None N
T/M 0.1024 likely_benign 0.1161 benign -0.059 Destabilizing 0.832 D 0.644 neutral None None None None N
T/N 0.1461 likely_benign 0.173 benign -0.99 Destabilizing 0.002 N 0.249 neutral N 0.499792332 None None N
T/P 0.281 likely_benign 0.3232 benign -0.538 Destabilizing 0.667 D 0.645 neutral N 0.510393328 None None N
T/Q 0.2791 likely_benign 0.3451 ambiguous -1.01 Destabilizing 0.567 D 0.655 neutral None None None None N
T/R 0.2052 likely_benign 0.2684 benign -0.658 Destabilizing 0.567 D 0.644 neutral None None None None N
T/S 0.1569 likely_benign 0.1875 benign -1.318 Destabilizing 0.004 N 0.279 neutral N 0.502061847 None None N
T/V 0.1211 likely_benign 0.1398 benign -0.538 Destabilizing 0.06 N 0.523 neutral None None None None N
T/W 0.5872 likely_pathogenic 0.6771 pathogenic -0.916 Destabilizing 0.968 D 0.698 prob.neutral None None None None N
T/Y 0.2716 likely_benign 0.3288 benign -0.651 Destabilizing 0.726 D 0.7 prob.neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.